Hoth Therapeutics, Inc. Common Stock (HOTH)
Hoth Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies for unmet medical needs. It emphasizes research in areas such as dermatology and neurological disorders, aiming to advance innovative treatments through strategic collaborations and proprietary platforms.
Company News
Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.7...
Are penny stocks worth investing in? The post Are Penny Stocks Worth the Risk? 3 Reasons Why They Could Be appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.